Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK unit pays £146 million to get Basilea eczema drug
GSK unit pays £146 million to get Basilea eczema drug
GSK unit pays £146 million to get Basilea eczema drug
Submitted by
admin
on June 12, 2012 - 10:56am
Source:
Pharma Times, UK
News Tags:
GSK
Basilea
eczema
Toctino
Stiefel Labs
Headline:
GSK unit pays £146 million to get Basilea eczema drug
Do Not Allow Advertisers to Use My Personal information
